Clinical implication and prognostic significance of the tumor suppressor <i>TSLC1</i> gene detected in adenocarcinoma of the lung
Kazuya Uchino(Akashi Medical Center), Morihito Okada(The University of Osaka), Chiho Ohbayashi(Hyogo Prefectural Cancer Center), Shoichi Iseki(Kanazawa University), Tomohiko Wakayama(Kumamoto University), Akihiko Ito(The University of Osaka), Tomoyo Okada(Memorial Sloan Kettering Cancer Center), Noriaki Tsubota(Akashi Medical Center), Yutaka Okita(Takatsuki General Hospital), Yukihiko Kitamura(Osaka University), Yu‐ichiro Koma(The University of Osaka)
Cited by 53
Related Papers
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839
EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ
|European Journal of Cardio-Thoracic Surgery|2023|373
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
2021 The American Association for Thoracic Surgery expert consensus document: Surgical treatment of acute type A aortic dissection
|Journal of Thoracic and Cardiovascular Surgery|2021|344
EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ
|The Annals of Thoracic Surgery|2024|286